KyungDong Pharm Co., Ltd. will release ‘Valdipine Plus Tablet’, a newly formulated three-drug combination drug for high blood pressure, on February 2nd.

‘Valdipine Plus Tablet’ contains three ingredients: valsartan of the angiotensin II receptor blocker (ARB) series, amlodipine, a calcium channel blocker (CCB), and chlorthalidone, a diuretic.

It is a new improved drug that combines three high blood pressure drugs.

A more powerful blood pressure lowering effect can be expected as the three ingredients with different mechanisms work in a complementary manner.

Taking fixed-dose combination drugs can improve patient compliance.

The release of ‘Valdipine Plus Tablet’ is expected to help KyungDong Pharm Co., Ltd. expand its main pipeline of antihypertensive drugs and improved new drugs and improve sales performance.

  

 

vProduct informationv

Product Name

baldipin®Plus Tablet

5/80/12.5mg

baldipin®Plus Tablet

5/160/12.5mg

baldipin®Plus Tablet

10/160/12.5mg

baldipin®Plus Tablet

10/160/25mg

Ingredients/Content

amlodipine besylate

6.94 mg

(5mg as amlodipine),

Valsartan 80 mg,

Chlorthalidone 12.5mg

amlodipine besylate

6.94 mg

(5mg as amlodipine),

Valsartan 160 mg,

Chlorthalidone 12.5mg

Amlodipine besylate 13.87mg

(10mg as amlodipine),

Valsartan 160 mg,

Chlorthalidone 12.5mg

Amlodipine besylate 13.84 mg

(10mg as amlodipine),

Valsartan 160 mg,

Chlorthalidone 25mg

Indications

Essential hypertension in which blood pressure is not adequately controlled with combination therapy of amlodipine and valsartan

Usage/Dosage

1 tablet once a day

drug price

933 won/tablet

1,137 won/tablet

1,199 won/tablet

1,219 won/tablet

Insurance claim code

648105300

648105290

648105270

648105280

Packaging unit

30 tablets/bottle